Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cooperative CAR targeting to selectively eliminate AML and minimize escape

Cancer Cell(2023)10.1016/j.ccell.2023.09.010Source: DataRank Database

Cooperative CAR targeting to selectively eliminate AML and minimize escape is a research paper published in Cancer Cell (2023). On theSindex it has a DataRank of 0. It has been cited 113 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access113 citations

Download PDF

Cite:

Linked data & code

cellosaurus nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 13.05)OA: hybridTopics (48)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Jorge Mansilla‐Soto ORCID,Sarah Nataraj ORCID,Friederike Kogel ORCID,Qing Chang ORCID,Elisa de Stanchina ORCID

Live enrichment

PubMed:37802054 PMC:PMC11006543 OpenAlex:https://openalex.org/W4387378062

NCI NIH HHS

Grant: P50 CA254838

NCI NIH HHS

Grant: P30 CA008748

FWCI

13.05

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.ccell.2023.09.010

publisherhttps://doi.org/10.1016/j.ccell.2023.09.010

publisherhttps://api.elsevier.com/content/article/PII:S1535610823003264?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1535610823003264?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37802054

Fields of Study

CAR-T cell therapy researchImmune Cell Function and InteractionCRISPR and Genetic EngineeringHumansAnimalsMiceCell Line, TumorT-LymphocytesLeukemia, Myeloid, AcuteImmunotherapy, AdoptiveHematopoietic Stem CellsReceptors, MitogenLectins, C-Type

MeSH Terms

AnimalsHematopoietic Stem CellsHumansReceptors, MitogenT-LymphocytesLeukemia, Myeloid, AcuteImmunotherapy, AdoptiveLectins, C-TypeCell Line, TumorMice

Keywords

Chimeric antigen receptorMyelopoiesisProgenitor cellHaematopoiesisCD19Cancer researchMyeloid leukemiaLeukemiaMyeloidAntigenStem cellBiologyImmunologyImmunotherapyCell biologyImmune systemAcute myeloid leukemiaHematotoxicityOff-target ToxicityOn-target ToxicityCar T Cell TherapyCombinatorial TargetingCooperative CarIcahtIf-better Gate

Sustainable Development Goals

SDG 0: Good health and well-being